A Study to Assess the Efficacy and Safety of Alefacept in Psoriasis Patients for Whom Conventional Treatment is Ineffective or Inappropriate
Clinical trial NCT00673556 · COMPLETED
Trial details
- NCT number
- NCT00673556
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-10-01
- Primary completion
- 2005-05-01
- Enrollment
- 195
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.